Fierce Medtech

The medtech industry’s most trusted source for news and analysis. Delivering news, revealing insights straight to your inbox.

[Fierce Medtech @FierceMedTech]

Foundation Medicine tallied another nod from the FDA for one of its genomic profiling tests that searches for specific biomarkers in tumor tissue samples. https://t.co/fZQhECD2MH

[Fierce Medtech @FierceMedTech]

Insulet issues voluntary correction for Omnipod devices https://t.co/8lT5IV3k3U

[Fierce Medtech @FierceMedTech]

Dexcom warned that some lots of its G7 wearable glucose monitors were stolen on their way to the scrapyard and were sold by a third-party vendor https://t.co/ckA8WXdO5y

[Fierce Medtech @FierceMedTech]

Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding biodegradable balloon spacer technology to its portfolio as the company broadens beyond its endoscopy stronghold https://t.co/9sssP3LjaS

[Fierce Medtech @FierceMedTech]

Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company whose flagship product delivers short-term electrical nerve stimulation for chronic pain patients, for approximately $650 million in cash https://t.co/zgyHMITnaa

[Fierce Medtech @FierceMedTech]

Endologix, a medtech that focuses on treatments for vascular diseases, expanded its offerings with the purchase of a mechanical thrombectomy system from Surmodics https://t.co/zqghWCLXDV

[Fierce Medtech @FierceMedTech]

Testing giant Labcorp is getting in on the lab results AI app act https://t.co/3v7HnUQ5k9

[Fierce Medtech @FierceMedTech]

Finnish biotech Herantis Pharma is teaming up with Swiss medtech Indivi to help seek early detection of Parkinson’s disease in a new proof-of-concept clinical trial. https://t.co/L74QpF5IaE

[Fierce Medtech @FierceMedTech]

Lauxera has nearly doubled the size of its first funding drive with a €520 million ($605 million) raise for health and medical technology companies. https://t.co/GKOZOJZiNZ

[Fierce Medtech @FierceMedTech]

Ardent Health taps Fujifilm’s AI-enabled patient imaging platform https://t.co/dtO4tpVCon

[Fierce Medtech @FierceMedTech]

Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system https://t.co/yNtTPhqKQ4

[FiercePharma @FiercePharma]

Despite prolonged policy uncertainty in the U.S., many healthcare and life sciences execs are still seeing opportunities amid the tumult.

On “The Top Line,” Fierce Pharma's Fraiser Kansteiner talks with @PwC's U.S. health industries leader about tariffs, drug pricing reform, AI and the future of U.S. healthcare innovation. https://t.co/KBpebv1VS0

[Fierce Medtech @FierceMedTech]

“Outliers are what you're going for,” Model Medicines CEO Daniel Haders told Fierce to explain the company's AI-driven drug development strategy. https://t.co/GCpZc46NtB

[Fierce Medtech @FierceMedTech]

New Hepta blood test could predict GLP-1 response https://t.co/DKpfb8aCHI

[FierceBiotech @FierceBiotech]

From shrinking drug development timelines to scouting potential acquisitions, the recent run of first-quarter earnings results marked a shift for Big Pharma from AI hype to explaining how the technology is being applied in practice. https://t.co/d2EybZcivC

[Fierce Medtech @FierceMedTech]

Insulet boosts guidance in Q1 update as it grapples with recall saga https://t.co/IePBFyU1Cv

[Fierce Medtech @FierceMedTech]

J&J is touting positive results from the first study of its soft-tissue surgical robot, showing the system can safely perform gastric bypass surgery. https://t.co/wJFFg8FbVp $JNJ

[Fierce Medtech @FierceMedTech]

Foundation Medicine links with Fulgent Genetics to offer new gene test https://t.co/9O2bphm7qK

[Fierce Medtech @FierceMedTech]

Sanofi expands AI capabilities, investing $294M to scale Toronto hub https://t.co/bFzhLNjzGB $SNY

[Fierce Medtech @FierceMedTech]

Olympus, EndoRobotics in distribution pact for robot-assisted endoscopic tech https://t.co/Tb4162Rmd7